4:30 PM
 | 
Aug 19, 2013
 |  BC Extra  |  Company News

Eisai wants DEA to schedule Fycompa

Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) asked the U.S. Court of Appeals for the District of Columbia to direct the U.S. Drug Enforcement Agency to schedule the pharma's Fycompa perampanel. FDA approved the epilepsy drug last October and sent its scheduling recommendation to the...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >